A Health Intervention to Prevent Depression Hepatitis C Patients
2016年12月28日 更新者:University of Texas Southwestern Medical Center
An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C
Interferon-alpha (IFN-α) is an efficacious treatment for Hepatitis C (HPC); however, IFN-α treatment results in a significant increase in depressive symptoms.
The aim of this project is to compare two health interventions (exercise vs. health education) to prevent depression in HPC patients receiving IFN-α.
Participants will be recruited from the Clinical Center for Liver Diseases at UT-Southwestern and randomized to 26 weeks of either: aerobic exercise or a health education control group.
研究概览
研究类型
介入性
注册 (实际的)
1
阶段
- 阶段2
- 第三阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Texas
-
Dallas、Texas、美国、75390-9119
- UT Southwestern Medical Center
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 65年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Diagnosed with Hepatitis C and prescribed IFN-α
- Ability to understand and willingness to provide written informed consent.
- Willing to provide contact information.
- Medical clearance with protocol-defined stress testing (in accordance with American College of Sports Medicine (ACSM) guidelines) from protocol approved medical personnel. Details of guidelines and related testing protocol are provided in the study Manual of Procedures.
- Able to comprehend and communicate in English.
Exclusion Criteria:
- Have a medical condition contraindicating exercise participation
- Are currently physically active - defined as moderate intensity physical activity on 3 or more days per week for the last month
- Have been diagnosed with current Major Depressive Disorder or are currently receiving antidepressant medication treatment (including SSRIs and SNRIs)
- Currently considered a high suicide risk and/or high risk for being unable to complete the study due to the need for psychiatric hospitalization, suicide attempts or suicidality, significant self-mutilation, or other self-injurious or destructive behavior based on the judgment of the site PI, medical personnel, or designee.
- Pregnancy.
- Current psychotic disorder. Other comorbid psychiatric diagnosis that, in the investigator's judgment, will pose a safety issue or make it difficult for the participant to understand or complete the intervention.
- Anticipated circumstances over the 6-month course of the trial that would render the participant unlikely to complete the study in the judgment of the PI or designee.
- Any reason not listed herein yet, determined by the PI, medical personnel, or designee that constitutes good clinical practice and that would in the opinion of the PI, medical personnel, or designee make participation in the study hazardous.
- Are currently enrolled in another research study, and participation in that study contraindicates participation in the current study
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Health Education
Participants will three attend heath education sessions per week for 26 weeks.
|
|
|
实验性的:Exercise
Participants will engage in a public health dose of moderate-to-vigorous aerobic exercise for 26 weeks.
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Change in Depressive Symptoms over 6 months
大体时间:Baseline, Weeks 3, 5, 7, 11, 15, 19, 23, 27
|
Baseline, Weeks 3, 5, 7, 11, 15, 19, 23, 27
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Change in Sleep Quality over 6 months
大体时间:Baseline, Weeks 3, 5, 7, 11, 15, 19, 23, 27
|
Baseline, Weeks 3, 5, 7, 11, 15, 19, 23, 27
|
|
Change in blood biomarkers over 6 months
大体时间:Baseline, Weeks 3, 5, 7, 11, 15, 19, 23, 27
|
Baseline, Weeks 3, 5, 7, 11, 15, 19, 23, 27
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Chad D Rethorst, Ph.D.、UT Southwestern Medical Center
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2013年6月1日
初级完成 (实际的)
2015年10月1日
研究完成 (实际的)
2015年10月1日
研究注册日期
首次提交
2013年6月5日
首先提交符合 QC 标准的
2013年6月26日
首次发布 (估计)
2013年7月1日
研究记录更新
最后更新发布 (估计)
2016年12月29日
上次提交的符合 QC 标准的更新
2016年12月28日
最后验证
2016年12月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.